Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities
Tiziana Di Chiara1, Antonino Tuttolomondo1, Gaspare Parrinello1
1Dipartimento PROMISE, University of Palermo, School of Medicine, Palermo, ltaly.
Insights
Obese individuals with left ventricular hypertrophy (LVH) exhibit distinct characteristics, including increased cardiometabolic risks and early systolic dysfunction. This suggests LVH may represent a unique obesity phenotype requiring targeted management.
Area of Science:
- Cardiology
- Obesity Medicine
- Metabolic Syndrome
Background:
- Obesity is linked to cardiac structural and functional changes due to hemodynamic and non-hemodynamic factors.
- Left ventricular hypertrophy (LVH) is a known cardiac adaptation in obesity.
- Understanding LVH's impact on systolic and diastolic function is crucial for managing cardiovascular risk in obese populations.
Purpose of the Study:
- To evaluate the prevalence of left ventricular hypertrophy (LVH) in obese patients.
- To assess the effects of LVH on left ventricular systolic and diastolic function in obese individuals.
- To identify clinical and biochemical markers associated with LVH in obesity.
Main Methods:
- Echocardiography and Doppler were used to measure left ventricular internal diameter (LVID), mass (LVM), mass index (LVMI), relative wall thickness (RWT), ejection fraction (LVEF), and diastolic parameters.
- Pulsed-wave Doppler assessed isovolumic relaxation time and deceleration time of E velocity.
- Radioimmunoassay measured total circulating adiponectin (ADPN) in 319 obese subjects with and without LVH.
Main Results:
- Obese subjects with LVH showed significantly higher BMI, waist-hip ratio (WHR), blood pressure, LVID, LVM, LVMI, and prevalence of hypertension, diabetes, and metabolic syndrome compared to controls.
- LVH subjects had lower adiponectin (ADPN) and LVEF, with no significant differences in diastolic parameters.
- LVEF correlated positively with ADPN and negatively with age, BMI, WHR, mean blood pressure (MBP), metabolic syndrome (MetS), and LVMI; WHR, MBP, LVMI, and ADPN were independent predictors of LVEF.
Conclusions:
- Obese individuals with LVH represent a distinct phenotype characterized by cardiac remodeling, cardiometabolic comorbidities, and central obesity.
- This phenotype is associated with hypoadiponectinemia and early left ventricular systolic dysfunction.
- Findings suggest LVH in obesity signifies an increased cardiovascular risk profile.
Abstract:
Background: It has been reported that changes in cardiac structure and ventricular function associated with obesity have to be attributable to hemodynamic and non-hemodynamic alterations. Accordingly, the aim of this was to evaluate left ventricular hypertrophy (LVH) prevalence and its effect on left ventricular systolic and diastolic function in a cohort of obese patients.Materials and Methods: LV internal diameter (LVID), left ventricular mass (LVM) and LVM/height2.7(LVMI), relative wall thickness (RWT), LV ejection fraction (LVEF), E/A ratio, isovolumic relaxation time, deceleration time of E velocity by echocardiography and pulsed-wave Doppler and total circulating adiponectin (ADPN) by radioimmunoassay were measured in 319 obese subjects with and without LVH.Results: Increased values of BMI, WHR, SBP, DBP, MBP LVID, LVM, LVMI, IVST (p < .001), increased prevalence of subjects with LVEF< 50%,(p < .001), central fat distribution (p < .001), hypertension (p < .001), diabetes (p < .001), metabolic syndrome (p < .02), and reduced value of ADPN (p < .0001) and LVEF (p < .001) were detected in LVH obese subjects than controls without LVH. No significant differences in diastolic parameters were observed between the two groups. LVEF correlated directly with ADPN (p < .0001) and inversely with age (p < .01), BMI (p < .01), WHR (p < .001), MBP (p < .01) MetS (p < .02) and LVMI (p < .001). WHR, MBP, LVMI and ADPN were independently associated with LVEF.Conclusions: In conclusion, our data indicate that obese subjects with LVH might be considered a distinct phenotype of obesity, characterised by LVH, increased prevalence of cardiometabolic comorbidities, central fat distribution, hypoadiponectinemia and early left ventricular systolic dysfunction.
More Related Videos
Related Concept Videos
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Measurement of Blood Pressure


